WAM
Weiss Asset Management’s Theravance Biopharma TBPH Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $82.3M | Hold |
7,457,060
| – | – | 0.95% | 10 |
|
2025
Q1 | $66.6M | Hold |
7,457,060
| – | – | 1.33% | 12 |
|
2024
Q4 | $70.2M | Hold |
7,457,060
| – | – | 1.31% | 11 |
|
2024
Q3 | $60.1M | Hold |
7,457,060
| – | – | 1.31% | 9 |
|
2024
Q2 | $63.2M | Hold |
7,457,060
| – | – | 2.39% | 4 |
|
2024
Q1 | $66.9M | Hold |
7,457,060
| – | – | 2.3% | 4 |
|
2023
Q4 | $83.8M | Hold |
7,457,060
| – | – | 4% | 2 |
|
2023
Q3 | $64.4M | Hold |
7,457,060
| – | – | 3.81% | 4 |
|
2023
Q2 | $77.2M | Hold |
7,457,060
| – | – | 5.92% | 1 |
|
2023
Q1 | $80.9M | Hold |
7,457,060
| – | – | 5.18% | 2 |
|
2022
Q4 | $83.7M | Hold |
7,457,060
| – | – | 3.41% | 2 |
|
2022
Q3 | $75.6M | Buy |
7,457,060
+1,219,622
| +20% | +$12.4M | 1.86% | 4 |
|
2022
Q2 | $56.5M | Buy |
6,237,438
+824,951
| +15% | +$7.47M | 1.38% | 10 |
|
2022
Q1 | $51.7M | Buy |
5,412,487
+2,810,709
| +108% | +$26.9M | 1.07% | 12 |
|
2021
Q4 | $28.8M | Buy |
+2,601,778
| New | +$28.8M | 0.62% | 22 |
|